Project Grant R56HL145053
Award Date
9/20/24
Completion Date
8/31/25
Dollars Obligated
$1.9M
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $900,000 in funding to Louisiana State University to conduct research on the impact of prenatal exposures to copper from electronic nicotine delivery system (ENDS) aerosols on the neonatal pulmonary immune system and IL-10-mediated asthmatic responses. The research aims to define the mechanisms by which prenatal ENDS exposure modulates the neonatal pulmonary...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $355,000 in funding from May 2025 to February 2029 to the Palo Alto Veterans Institute for Research (PAVIR) to study the transgenerational effects of e-cigarette use on the development of abdominal aortic aneurysm (AAA) disease. The key goals are to examine how e-cigarette vapor and nicotine exposure can cause epigenetic changes that are transmitted across...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA 93.077 Family Smoking Prevention and Tobacco Control Act Regulatory Research program provides $3,230,000 to The Regents of the University of California, San Francisco (UCSF) to investigate the cardiovascular effects of dual use of tobacco and nicotine delivery products like cigarettes and e-cigarettes. The project aims to (1) understand the cardiovascular health effects of dual use...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $187,500.00 to North Carolina Central University (NCCU) to assess the immunosuppressive effects of e-cigarette (e-cig) usage and its impact on susceptibility to pulmonary infections. The key objectives are to: 1) model lung cell immune dysfunction using human bronchial epithelial cells, 2) assess immune cell involvement and lung...
This federal Project Grant award, titled "ENDS Aerosol Particle Deposition, In Utero Exposures and Children's Respiratory Health Effects (ENDURE)", was provided by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program. The grant, totaling $720,855, aims to investigate the impacts of in utero exposure to electronic nicotine delivery system (ENDS) aerosols on offspring respiratory health. The key products and services to be...
This $1,257,395 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI)'s Cardiovascular Diseases Research program (CFDA 93.837) aims to quantify the long-term effects of e-cigarette use on cardiovascular and pulmonary health. The study will recruit 400 long-term e-cigarette users and 200 non-users to undergo comprehensive biomarker assessments over 36 months, including measures of cardiovascular health, lung function, and nicotine dependence. The primary objectives are to...
This $619,477 federal Project Grant awarded by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program supports research to investigate the impact of electronic cigarette (e-cigarette) exposure, both direct and in-utero, on vascular function and cognitive decline. The research, conducted by the West Virginia University Research Corporation, aims to establish the dose-dependent effects of e-cigarette exposure on vascular dysfunction and...
This Project Grant award from the National Institutes of Health (NIH) under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $1,197,896 to the University of Oklahoma Health Sciences Center to conduct a longitudinal study examining the impact of electronic nicotine delivery system (ENDS) product characteristics on use behaviors and abuse liability among young adults. The study will utilize a combination of traditional survey methods and...
This federal Project Grant award, provided under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) by the National Institutes of Health Office of the Director, is funding a study to investigate the exposure and health effects of chemical constituents from electronic cigarette (e-cigarette) use among young adults. The primary objectives are to: 1) evaluate the relationship between e-cigarette use and exposure to metals and aldehydes, 2) assess the...
This Project Grant award of $1,315,596 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to investigate the effects of maternal exposure to electronic nicotine delivery system (ENDS) aerosols during pregnancy on addiction-related behaviors and neurobiology in offspring. The primary objectives are to examine the impacts of maternal ENDS aerosol exposure on measures of impulsivity, nicotine abuse liability, and function of...